93 related articles for article (PubMed ID: 10588619)
1. Cerebral bioenergetics in stable chronic obstructive pulmonary disease.
Mathur R; Cox IJ; Oatridge A; Shephard DT; Shaw RJ; Taylor-Robinson SD
Am J Respir Crit Care Med; 1999 Dec; 160(6):1994-9. PubMed ID: 10588619
[TBL] [Abstract][Full Text] [Related]
2. Muscle energy metabolism and nutritional status in patients with chronic obstructive pulmonary disease. A 31P magnetic resonance study.
Kutsuzawa T; Shioya S; Kurita D; Haida M; Ohta Y; Yamabayashi H
Am J Respir Crit Care Med; 1995 Aug; 152(2):647-52. PubMed ID: 7633721
[TBL] [Abstract][Full Text] [Related]
3. Decreased phosphorus metabolite concentrations and alkalosis in chronic cerebral infarction.
Sappey-Marinier D; Hubesch B; Matson GB; Weiner MW
Radiology; 1992 Jan; 182(1):29-34. PubMed ID: 1727305
[TBL] [Abstract][Full Text] [Related]
4. Metabolism and aerobic capacity of skeletal muscle in chronic respiratory failure related to chronic obstructive pulmonary disease.
Wuyam B; Payen JF; Levy P; Bensaïdane H; Reutenauer H; Le Bas JF; Benabid AL
Eur Respir J; 1992 Feb; 5(2):157-62. PubMed ID: 1559579
[TBL] [Abstract][Full Text] [Related]
5. [Skeletal muscle abnormalities in chronic obstructive lung disease with respiratory insufficiency. Value of P31 magnetic resonance spectroscopy].
Lévy P; Wuyam B; Pépin JL; Reutenauer H; Payen JF
Rev Mal Respir; 1997 Jun; 14(3):183-91. PubMed ID: 9411595
[TBL] [Abstract][Full Text] [Related]
6. Bio-energetic impairment in human calf muscle in thyroid disorders: a 31P MRS study.
Khushu S; Rana P; Sekhri T; Sripathy G; Tripathi RP
Magn Reson Imaging; 2010 Jun; 28(5):683-9. PubMed ID: 20332062
[TBL] [Abstract][Full Text] [Related]
7. Effect of functional grade and etiology on in vivo hepatic phosphorus-31 magnetic resonance spectroscopy in cirrhosis: biochemical basis of spectral appearances.
Menon DK; Sargentoni J; Taylor-Robinson SD; Bell JD; Cox IJ; Bryant DJ; Coutts GA; Rolles K; Burroughs AK; Morgan MY
Hepatology; 1995 Feb; 21(2):417-27. PubMed ID: 7843715
[TBL] [Abstract][Full Text] [Related]
8. Muscular metabolism during oxygen supplementation in patients with chronic hypoxemia.
Payen JF; Wuyam B; Levy P; Reutenauer H; Stieglitz P; Paramelle B; Le Bas JF
Am Rev Respir Dis; 1993 Mar; 147(3):592-8. PubMed ID: 8442592
[TBL] [Abstract][Full Text] [Related]
9. Human focal cerebral ischemia: evaluation of brain pH and energy metabolism with P-31 NMR spectroscopy.
Levine SR; Helpern JA; Welch KM; Vande Linde AM; Sawaya KL; Brown EE; Ramadan NM; Deveshwar RK; Ordidge RJ
Radiology; 1992 Nov; 185(2):537-44. PubMed ID: 1410369
[TBL] [Abstract][Full Text] [Related]
10. Localised cerebral phosphorus-31 MR spectroscopy in man before and immediately after coronary bypass surgery with hypothermic cardiopulmonary bypass.
Wilson JA; Taylor-Robinson SD; Bryant DJ; Taylor KM; Harris DN
Metab Brain Dis; 1998 Sep; 13(3):191-200. PubMed ID: 9804364
[TBL] [Abstract][Full Text] [Related]
11. Metabolic activity in skeletal muscles of patients with non-hypoxaemic chronic obstructive pulmonary disease studied by 31P-magnetic resonance spectroscopy.
Hamaoka T; Tatsumi K; Saito Y; Arai Y; Horie Y; Masuyama S; Tanabe N; Takiguchi Y; Ikehira H; Obata T; Sasaki Y; Tanada S; Kuriyama T
Respirology; 2005 Mar; 10(2):164-70. PubMed ID: 15823180
[TBL] [Abstract][Full Text] [Related]
12. Unique aspects of human newborn cerebral metabolism evaluated with phosphorus nuclear magnetic resonance spectroscopy.
Younkin DP; Delivoria-Papadopoulos M; Leonard JC; Subramanian VH; Eleff S; Leigh JS; Chance B
Ann Neurol; 1984 Nov; 16(5):581-6. PubMed ID: 6508240
[TBL] [Abstract][Full Text] [Related]
13. In vivo evidence for cerebral depletion in high-energy phosphates in progressive supranuclear palsy.
Stamelou M; Pilatus U; Reuss A; Magerkurth J; Eggert KM; Knake S; Ruberg M; Schade-Brittinger C; Oertel WH; Höglinger GU
J Cereb Blood Flow Metab; 2009 Apr; 29(4):861-70. PubMed ID: 19190655
[TBL] [Abstract][Full Text] [Related]
14. High energy phosphate metabolism in experimental permanent focal cerebral ischemia: an in vivo 31P magnetic resonance spectroscopy study.
Germano IM; Pitts LH; Berry I; De Armond SJ
J Cereb Blood Flow Metab; 1988 Feb; 8(1):24-31. PubMed ID: 3339105
[TBL] [Abstract][Full Text] [Related]
15. Value of dynamic ³¹P magnetic resonance spectroscopy technique in in vivo assessment of the skeletal muscle mitochondrial function in type 2 diabetes.
Wu FY; Tu HJ; Qin B; Chen T; Xu HF; Qi J; Wang DH
Chin Med J (Engl); 2012 Jan; 125(2):281-6. PubMed ID: 22340560
[TBL] [Abstract][Full Text] [Related]
16. Phosphorus magnetic resonance spectroscopy (31P MRS) in neuromuscular disorders.
Argov Z; Bank WJ
Ann Neurol; 1991 Jul; 30(1):90-7. PubMed ID: 1834009
[TBL] [Abstract][Full Text] [Related]
17. Phosphorus 31 nuclear magnetic resonance spectroscopy suggests a mitochondrial defect in claudicating skeletal muscle.
Pipinos II; Shepard AD; Anagnostopoulos PV; Katsamouris A; Boska MD
J Vasc Surg; 2000 May; 31(5):944-52. PubMed ID: 10805885
[TBL] [Abstract][Full Text] [Related]
18. Cerebral metabolism in streptozotocin-diabetic rats: an in vivo magnetic resonance spectroscopy study.
Biessels GJ; Braun KP; de Graaf RA; van Eijsden P; Gispen WH; Nicolay K
Diabetologia; 2001 Mar; 44(3):346-53. PubMed ID: 11317667
[TBL] [Abstract][Full Text] [Related]
19. Quantitative in vivo 31P magnetic resonance spectroscopy of Alzheimer disease.
Gonzalez RG; Guimaraes AR; Moore GJ; Crawley A; Cupples LA; Growdon JH
Alzheimer Dis Assoc Disord; 1996; 10(1):46-52. PubMed ID: 8919496
[TBL] [Abstract][Full Text] [Related]
20. Elevated inosine monophosphate levels in resting muscle of patients with stable chronic obstructive pulmonary disease.
Pouw EM; Schols AM; van der Vusse GJ; Wouters EF
Am J Respir Crit Care Med; 1998 Feb; 157(2):453-7. PubMed ID: 9476857
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
